- Home
- TARA vs NAUT Comparison
TARA vs NAUT Comparison
Compare TARA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | NAUT |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 305.7M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TARA | NAUT |
|---|---|---|
| Price | $5.71 | $2.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $21.86 | $4.00 |
| AVG Volume (30 Days) | ★ 1.1M | 218.8K |
| Earning Date | 06-18-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $0.62 |
| 52 Week High | $7.82 | $3.08 |
Technical Indicators
Market Signals| Indicator | TARA | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 49.94 |
| Support Level | $4.87 | $1.82 |
| Resistance Level | $5.77 | $3.08 |
| Average True Range (ATR) | 0.54 | 0.29 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 17.27 | 25.82 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.